Hims & Hers Health (NYSE:HIMS) Shares Gap Down to $16.05

Hims & Hers Health, Inc. (NYSE:HIMS) shares gapped down before the market opened on Tuesday . The stock had previously closed at $16.05, but opened at $14.82. Hims & Hers Health shares last traded at $15.15, with a volume of 3,776,513 shares.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Imperial Capital downgraded Hims & Hers Health from an “outperform” rating to an “in-line” rating in a research note on Friday, August 9th. Piper Sandler reissued a “neutral” rating and issued a $18.00 price target on shares of Hims & Hers Health in a research report on Tuesday, August 6th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Hims & Hers Health from $16.00 to $23.00 and gave the stock a “hold” rating in a report on Wednesday, August 7th. Bank of America increased their target price on shares of Hims & Hers Health from $22.00 to $26.00 and gave the company a “buy” rating in a report on Thursday, June 13th. Finally, Jefferies Financial Group boosted their price target on shares of Hims & Hers Health from $14.00 to $23.00 and gave the stock a “hold” rating in a report on Thursday, June 27th. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, Hims & Hers Health currently has an average rating of “Moderate Buy” and an average price target of $20.29.

Hims & Hers Health Stock Performance

The company’s 50 day moving average price is $19.77 and its 200-day moving average price is $16.56. The company has a market cap of $3.25 billion, a PE ratio of -1,515.00 and a beta of 1.08.

Hims & Hers Health (NYSE:HIMS) last released its earnings results on Monday, August 5th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Hims & Hers Health had a negative return on equity of 0.70% and a negative net margin of 0.24%. The business had revenue of $315.65 million during the quarter, compared to the consensus estimate of $302.43 million. During the same period last year, the business posted ($0.03) earnings per share. The business’s revenue for the quarter was up 51.8% on a year-over-year basis. Equities research analysts expect that Hims & Hers Health, Inc. will post 0.2 EPS for the current year.

Insider Activity at Hims & Hers Health

In other Hims & Hers Health news, insider Michael Chi sold 2,054 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $22.00, for a total transaction of $45,188.00. Following the completion of the transaction, the insider now owns 185,326 shares in the company, valued at $4,077,172. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Hims & Hers Health news, insider Soleil Boughton sold 2,334 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $17.30, for a total value of $40,378.20. Following the completion of the transaction, the insider now owns 164,475 shares in the company, valued at approximately $2,845,417.50. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Michael Chi sold 2,054 shares of Hims & Hers Health stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $22.00, for a total value of $45,188.00. Following the transaction, the insider now directly owns 185,326 shares of the company’s stock, valued at approximately $4,077,172. The disclosure for this sale can be found here. In the last three months, insiders have sold 966,516 shares of company stock worth $19,217,516. Company insiders own 17.71% of the company’s stock.

Hedge Funds Weigh In On Hims & Hers Health

Large investors have recently modified their holdings of the company. Nisa Investment Advisors LLC boosted its stake in Hims & Hers Health by 679.2% during the second quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock valued at $37,000 after buying an additional 1,603 shares during the period. Quest Partners LLC boosted its position in shares of Hims & Hers Health by 5,944.1% during the 2nd quarter. Quest Partners LLC now owns 3,566 shares of the company’s stock valued at $72,000 after acquiring an additional 3,507 shares during the last quarter. Certuity LLC purchased a new position in shares of Hims & Hers Health during the fourth quarter worth about $109,000. Van ECK Associates Corp purchased a new position in shares of Hims & Hers Health during the second quarter worth about $111,000. Finally, Belpointe Asset Management LLC increased its position in shares of Hims & Hers Health by 10.0% in the fourth quarter. Belpointe Asset Management LLC now owns 13,238 shares of the company’s stock worth $118,000 after purchasing an additional 1,205 shares during the last quarter. 63.52% of the stock is currently owned by institutional investors.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.